tiprankstipranks
Trending News
More News >
Prostatype Genomics AB (SE:PROGEN)
:PROGEN
Sweden Market

Prostatype Genomics AB (PROGEN) Income Statement

Compare
0 Followers

Prostatype Genomics AB Income Statement

Last quarter (Q2 2025), Prostatype Genomics AB's total revenue was kr123.00K, a decrease of -83.02% from the same quarter last year. In Q2, Prostatype Genomics AB's net income was kr-11.96M. See Prostatype Genomics AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 594.00Kkr 199.00Kkr 1.36Mkr 683.00Kkr 10.00K
Gross Profit
kr -37.62Mkr 1.92Mkr 3.73Mkr 683.00Kkr 2.51M
Operating Expenses
kr 1.46Mkr 42.77Mkr 42.98Mkr 29.37Mkr 18.06M
Depreciation and Amortization
kr 2.19Mkr 1.98Mkr 1.88Mkr 1.90Mkr 88.48K
EBITDA
kr -36.89Mkr -37.40Mkr -38.02Mkr -26.79Mkr -15.46M
Operating Income
kr -39.08Mkr -40.85Mkr -39.25Mkr -28.69Mkr -15.55M
Other Income/Expenses
kr -5.42Mkr -198.00Kkr -2.19Mkr -398.00Kkr -81.49K
Pretax Income
kr -44.50Mkr -41.05Mkr -41.44Mkr -29.09Mkr -15.63M
Net Income
kr -44.50Mkr -41.05Mkr -41.44Mkr -29.09Mkr -15.63M
Per Share Metrics
Basic EPS
kr -1.32kr -13.67kr -12.04kr -12.59kr -10.64
Diluted EPS
kr -1.32kr -13.67kr -12.04kr -7.72kr -10.64
Weighted Average Shares Outstanding
33.78M 3.00M 3.44M 2.31M 1.47M
Weighted Average Shares Outstanding (Diluted)
33.78M 3.00M 3.44M 3.77M 1.47M
Currency in SEK

Prostatype Genomics AB Earnings and Revenue History